
AirSeal CardioVascular presented by Mohamed Zayed MD, Co-founder
AirSeal CardioVascular is a medical diagnostics company that aims to transform how doctors and hospital systems diagnose individuals with cardiovascular disease and associated risk factors. Peripheral Arterial Disease (PAD) affects more than 12 million Americans and is one of the leading causes of heart attack, stroke, limb loss, and cardiovascular death, yet millions of patients remain undiagnosed until they develop advanced disease. Our goal is to fundamentally change that by providing clinicians with a simple blood test that can identify patients much earlier, when interventions are most effective.






